Verisante Technology Inc. (VRSEF)
USD 0.01
(233.33%)
USD 0.01
(233.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -136.26 Thousand CAD | 52.68% |
| 2022 | -287.99 Thousand CAD | -49.8% |
| 2021 | -192.25 Thousand CAD | -20.64% |
| 2020 | -159.36 Thousand CAD | -2.0% |
| 2019 | -156.24 Thousand CAD | 53.5% |
| 2018 | -335.98 Thousand CAD | 82.94% |
| 2017 | -1.96 Million CAD | -29.8% |
| 2016 | -1.51 Million CAD | 37.07% |
| 2015 | -2.41 Million CAD | 27.94% |
| 2014 | -3.34 Million CAD | 31.84% |
| 2013 | -4.9 Million CAD | -38.5% |
| 2012 | -3.54 Million CAD | 0.35% |
| 2011 | -3.55 Million CAD | -115.92% |
| 2010 | -1.64 Million CAD | -46.29% |
| 2009 | -1.12 Million CAD | -20.93% |
| 2008 | -931.23 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -28.44 Thousand CAD | 11.4% |
| 2024 Q1 | -32.1 Thousand CAD | 15.23% |
| 2023 Q3 | -31.58 Thousand CAD | -1.53% |
| 2023 FY | -136.27 Thousand CAD | 52.68% |
| 2023 Q4 | -37.87 Thousand CAD | -19.91% |
| 2023 Q1 | -35.7 Thousand CAD | 22.96% |
| 2023 Q2 | -31.1 Thousand CAD | 12.89% |
| 2022 Q1 | -101.71 Thousand CAD | -16.99% |
| 2022 Q4 | -46.34 Thousand CAD | 41.1% |
| 2022 Q2 | -63.24 Thousand CAD | 37.82% |
| 2022 Q3 | -78.68 Thousand CAD | -24.42% |
| 2022 FY | -287.99 Thousand CAD | -49.8% |
| 2021 Q4 | -86.93 Thousand CAD | -129.21% |
| 2021 FY | -192.25 Thousand CAD | -20.64% |
| 2021 Q1 | -33.49 Thousand CAD | 0.0% |
| 2021 Q2 | -33.88 Thousand CAD | -1.17% |
| 2021 Q3 | -37.93 Thousand CAD | -11.93% |
| 2020 FY | -159.36 Thousand CAD | -2.0% |
| 2019 FY | -156.24 Thousand CAD | 53.5% |
| 2018 FY | -335.98 Thousand CAD | 82.94% |
| 2017 FY | -1.96 Million CAD | -29.8% |
| 2017 Q2 | -275.12 Thousand CAD | 23.57% |
| 2017 Q3 | -213.69 Thousand CAD | 22.33% |
| 2017 Q1 | -359.95 Thousand CAD | -6.17% |
| 2017 Q4 | -1.1 Million CAD | -416.55% |
| 2016 Q4 | -339.04 Thousand CAD | 0.69% |
| 2016 FY | -1.51 Million CAD | 37.07% |
| 2016 Q3 | -341.4 Thousand CAD | 18.3% |
| 2016 Q1 | -419.01 Thousand CAD | 46.33% |
| 2016 Q2 | -417.88 Thousand CAD | 0.27% |
| 2015 Q2 | -528.97 Thousand CAD | 12.96% |
| 2015 Q4 | -780.77 Thousand CAD | -58.2% |
| 2015 FY | -2.41 Million CAD | 27.94% |
| 2015 Q1 | -607.72 Thousand CAD | 33.18% |
| 2015 Q3 | -493.54 Thousand CAD | 6.7% |
| 2014 Q2 | -682.08 Thousand CAD | 34.3% |
| 2014 FY | -3.34 Million CAD | 31.84% |
| 2014 Q1 | -1.03 Million CAD | 43.32% |
| 2014 Q4 | -909.56 Thousand CAD | -27.03% |
| 2014 Q3 | -716.01 Thousand CAD | -4.97% |
| 2013 Q1 | -1.18 Million CAD | 12.97% |
| 2013 Q3 | -751.05 Thousand CAD | 34.26% |
| 2013 FY | -4.9 Million CAD | -38.5% |
| 2013 Q4 | -1.83 Million CAD | -143.89% |
| 2013 Q2 | -1.14 Million CAD | 3.5% |
| 2012 Q4 | -1.36 Million CAD | -92.16% |
| 2012 Q1 | -807.66 Thousand CAD | 25.15% |
| 2012 Q3 | -707.92 Thousand CAD | -5.9% |
| 2012 FY | -3.54 Million CAD | 0.35% |
| 2012 Q2 | -668.46 Thousand CAD | 17.23% |
| 2011 Q3 | -1 Million CAD | -29.77% |
| 2011 Q2 | -772.52 Thousand CAD | -9.9% |
| 2011 FY | -3.55 Million CAD | -115.92% |
| 2011 Q1 | -702.89 Thousand CAD | -31.31% |
| 2011 Q4 | -1.07 Million CAD | -7.64% |
| 2010 Q2 | -383.16 Thousand CAD | -10.19% |
| 2010 Q1 | -347.73 Thousand CAD | 15.3% |
| 2010 Q4 | -535.28 Thousand CAD | -40.42% |
| 2010 FY | -1.64 Million CAD | -46.29% |
| 2010 Q3 | -381.21 Thousand CAD | 0.51% |
| 2009 Q1 | -221.5 Thousand CAD | 11.88% |
| 2009 FY | -1.12 Million CAD | -20.93% |
| 2009 Q4 | -410.56 Thousand CAD | -89.52% |
| 2009 Q3 | -216.63 Thousand CAD | 21.9% |
| 2009 Q2 | -277.38 Thousand CAD | -25.22% |
| 2008 Q3 | -244.12 Thousand CAD | 0.0% |
| 2008 FY | -931.23 Thousand CAD | 0.0% |
| 2008 Q4 | -251.36 Thousand CAD | -2.97% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -703 Thousand USD | 80.616% |
| SS Innovations International, Inc. | -20.66 Million USD | 99.341% |
| Össur hf. | 87.46 Million USD | 100.156% |
| Össur hf. | 87.46 Million USD | 100.156% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | -240.15 Thousand USD | 43.259% |
| BrainsWay Ltd. | -4.92 Million USD | 97.234% |
| BioElectronics Corporation | -274.29 Thousand USD | 50.319% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.663% |
| Zecotek Photonics Inc. | -3.65 Million USD | 96.274% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | -1.79 Million USD | 92.407% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 149.018% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 106.548% |
| Escalon Medical Corp. | -104.47 Thousand USD | -30.431% |
| Aurora Spine Corporation | -446.19 Thousand USD | 69.46% |
| NewCardio, Inc. | -9.45 Million USD | 98.559% |
| Avitar, Inc. | 2.73 Million USD | 104.986% |
| Vivos Inc. | -2.79 Million USD | 95.121% |
| Theraclion SA | -3.48 Million USD | 96.085% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 43.023% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 92.308% |
| Positron Corporation | -1.36 Million USD | 89.986% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 64.036% |
| Nanomix Corporation | -8.43 Million USD | 98.385% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 80.727% |
| Stratec SE | 25.26 Million USD | 100.539% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.942% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -13.062% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 93.401% |
| Lombard Medical, Inc. | -29.33 Million USD | 99.535% |
| ALR Technologies Inc. | -2.94 Million USD | 95.375% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.974% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 439.054% |
| VMS Rehab Systems, Inc. | -68.66 USD | -198369.269% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 99.343% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 96.058% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 74.765% |
| Ingen Technologies, Inc. | -1.61 Million USD | 91.555% |
| United American Healthcare Corporation | -67 Thousand USD | -103.387% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.956% |
| IR-Med Inc. | -4.91 Million USD | 97.225% |
| Polarean Imaging plc | -12.55 Million USD | 98.915% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 66.558% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 78.53% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 77.346% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 131.099% |
| Urologix, Inc. | -6.93 Million USD | 98.034% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 89.214% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 97.825% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 40.815% |
| Smith & Nephew plc | 425 Million USD | 100.032% |
| NIOX Group Plc | 4.6 Million USD | 102.962% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 135.503% |
| Broncus Holding Corporation | -33.22 Million USD | 99.59% |
| Brain Scientific Inc. | -9.6 Million USD | 98.582% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 98.566% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -124.5% |